BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2010
View Archived Issues
Cornerstone completes private equity financing for CPI-613
Read More
ResearchPoint and Azaya enroll first patient in phase I ATI-1123 study
Read More
Biomarkers for pancreatic cancer identified via proximity ligation assay
Read More
Neuroprotection seen with MGF-24 may be beneficial in Parkinson's disease
Read More
Studies with tropisetron indicate that 5-HT3R is an antiobesity target
Read More
European Commission approves Roche's Herceptin for HER2-positive stomach cancer
Read More
Ark enrolls first patient in phase I/IIa trial of EG-011 in refractory angina
Read More
Palatin Technologies claims MCR ligands for the treatment of sexual dysfunction
Read More
Merck & Co. discloses NS5B inhibitors for HCV infection
Read More
National Health Research Institutes describes coumarins for cancer therapy
Read More
University of Toledo reports M1 agonists for the treatment of mental disorders
Read More
GlaxoSmithKline identifies novel PI3K inhibitors for asthma therapy
Read More
New highly sensitive assay links troponin T concentrations to CAD
Read More
Sodium phenylbutyrate reduces macrophage ER stress and lipotoxicity in atherosclerosis
Read More
Pharmasset initiates phase IIa PSI-7977 trial in HCV
Read More
Aegera initiates phase II AEG-35156 study for hepatocellular carcinoma
Read More
FDA approves Bayer's phase I study with personalized vaccine from tobacco plants
Read More
NCI initiates study for ImmuneRegen's vaccine adjuvant candidate
Read More
FDA extends PDUFA action date for Sepracor's NDA for Stedesa
Read More
MedCI enters alliance with Genta to secure licensing partners for tesetaxel
Read More
Repros receives guidance from FDA on Androxal in secondary hypogonadism
Read More
Cytokinetics reports data from phase I multiple dose CK-2017357 trial
Read More
Tripep presents update for ChronVac-C-study
Read More
ALS Therapy Development Institute and Oxford BioMedica extend collaboration
Read More
Warner Chilcott received complete response letter for low dose oral contraceptive
Read More